Sinoway Industrial Co., Ltd.

Pitavastatin Calcium 147526-32-7 Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Related Products
  • L-Glutathione Reduced (GSH) 70-18-8

    L-Glutathione ReducedBasic information of L-Glutathione Reduced:Product name: L-Glutathione ReducedMolecular Formula : C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc...

  • Copper Peptide (GHK)2-CU 49557-75-7

    Copper peptide GHK-CuBasic information of copper peptide GHK-Cu :Product Name(GHK)2-Cu(Copper Peptide)SynonymsGHK-Cu (Copper peptide)CAS #49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2...

  • Isoflavones in Soy 574-12-9

    Soybean Extract1.Basic information of Soybean Extract:Product name: Soybean ExtractSource: glycine maxUsed part: germ/bean pulpSpec.: total soy isoflavone 40%, 80% by HPLCNameSoybean Extract PowderTyp...

Basic information of Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Usage of Pitavastatin Calcium 147526-32-7

  • Pitavastatin calcium is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease.

COA of Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatin Calcium 147526-32-7

Basic information of Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Usage of Pitavastatin Calcium 147526-32-7

  • Pitavastatin calcium is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease.

COA of Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//